Scotiabank Maintains Sector Outperform on Pfizer, Raises Price Target to $35
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
Scotiabank analyst Louise Chen maintains Pfizer (NYSE:PFE) with a Sector Outperform and raises the price target from $33 to $35.
Scotiabank analyst Louise Chen maintains Pfizer (NYSE:PFE) with a Sector Outperform and raises the price target from $33 to $35.